Komboglyze (saxagliptin and metformin HCl)

Komboglyze^{TM 1} (saxagliptin and metformin HCl) is an immediate release fixed dose combination indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients with Type 2 diabetes mellitus inadequately controlled on their maximally tolerated dose of metformin alone or those already being treated with the combination of saxagliptin and metformin as separate tablets.

¹ - Co-developed and co-commercialised with BMS